Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9070)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2015 (publication date) through May 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang T, Jiang B, Zou ST, Liu F, Hua D. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. World J Gastroenterol 2015; 21(6): 1804-1813 [PMID: 25684945 DOI: 10.3748/wjg.v21.i6.1804] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i6/1804.htm |
| Number | Citing Articles |
| 1 |
Karine Flem-Karlsen, Øystein Fodstad, Caroline E. Nunes-Xavier. B7-H3 Immune Checkpoint Protein in Human Cancer. Current Medicinal Chemistry 2020; 27(24): 4062 doi: 10.2174/0929867326666190517115515
|
| 2 |
Petar Rasic, Marija Jeremic, Rada Jeremic, Marija Dusanovic Pjevic, Milica Rasic, Slavisa M. Djuricic, Maja Milickovic, Miroslav Vukadin, Tanja Mijovic, Djordje Savic. Targeting B7-H3—A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment. Molecules 2023; 28(8): 3356 doi: 10.3390/molecules28083356
|
| 3 |
Tongguo Shi, Yanchao Ma, Lei Cao, Shenghua Zhan, Yunyun Xu, Fengqing Fu, Cuiping Liu, Guangbo Zhang, Zhenxin Wang, Ruoqin Wang, Huimin Lu, Binfeng Lu, Weichang Chen, Xueguang Zhang. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. Cell Death & Disease 2019; 10(4) doi: 10.1038/s41419-019-1549-6
|
| 4 |
Barry Paul, Bert H O’Neil, Autumn J McRee. Checkpoint Inhibition for Colorectal Cancer: Progress and Possibilities. Immunotherapy 2016; 8(6): 693 doi: 10.2217/imt-2016-0013
|
| 5 |
Gen Li, Yanchun Quan, Fengyuan Che, Lijuan Wang. B7-H3 in tumors: friend or foe for tumor immunity?. Cancer Chemotherapy and Pharmacology 2018; 81(2): 245 doi: 10.1007/s00280-017-3508-1
|
| 6 |
Yohei Tsuchida, Jianyong Zhong, Tadashi Otsuka, Anna Dikalova, Ira Pastan, G.M. Anantharamaiah, MacRae F. Linton, Patricia G. Yancey, T. Alp Ikizler, Agnes B. Fogo, Haichun Yang, Valentina Kon. Lipoprotein modulation of proteinuric renal injury. Laboratory Investigation 2019; 99(8): 1107 doi: 10.1038/s41374-019-0253-6
|
| 7 |
Justyna A. Wierzbinska, Reka Toth, Naveed Ishaque, Karsten Rippe, Jan-Philipp Mallm, Lara C. Klett, Daniel Mertens, Thorsten Zenz, Thomas Hielscher, Marc Seifert, Ralf Küppers, Yassen Assenov, Pavlo Lutsik, Stephan Stilgenbauer, Philipp M. Roessner, Martina Seiffert, John Byrd, Christopher C. Oakes, Christoph Plass, Daniel B. Lipka. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL. Genome Medicine 2020; 12(1) doi: 10.1186/s13073-020-00724-7
|
| 8 |
Yixuan Li, Qian Cai, Ximing Shen, Xiaoting Chen, Zhong Guan. Overexpression of B7-H3 Is Associated With Poor Prognosis in Laryngeal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.759528
|
| 9 |
Marina Digregorio, Natacha Coppieters, Arnaud Lombard, Paul Noel Lumapat, Felix Scholtes, Bernard Rogister. The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role. Acta Neuropathologica Communications 2021; 9(1) doi: 10.1186/s40478-021-01167-w
|
| 10 |
Christina Guo, Ines Figueiredo, Bora Gurel, Antje Neeb, George Seed, Mateus Crespo, Suzanne Carreira, Jan Rekowski, Lorenzo Buroni, Jon Welti, Denisa Bogdan, Lewis Gallagher, Adam Sharp, Maria D. Fenor de la Maza, Pasquale Rescigno, Daniel Westaby, Khobe Chandran, Ruth Riisnaes, Ana Ferreira, Susana Miranda, Bianca Calì, Andrea Alimonti, Silvia Bressan, Alana H.T. Nguyen, Michael M. Shen, Jessica E. Hawley, Aleksandar Obradovic, Charles G. Drake, Claudia Bertan, Chloe Baker, Nina Tunariu, Wei Yuan, Johann S. de Bono. B7-H3 as a Therapeutic Target in Advanced Prostate Cancer. European Urology 2023; 83(3): 224 doi: 10.1016/j.eururo.2022.09.004
|
| 11 |
Nan Li, Madeline R. Spetz, Dan Li, Mitchell Ho. Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3. Pharmacology & Therapeutics 2021; 223: 107892 doi: 10.1016/j.pharmthera.2021.107892
|
| 12 |
Haibo Zhang, Jinsen Zhang, Chunjie Li, Hao Xu, Rui Dong, Clark C. Chen, Wei Hua. Survival Association and Cell Cycle Effects of B7H3 in Neuroblastoma. Journal of Korean Neurosurgical Society 2020; 63(6): 707 doi: 10.3340/jkns.2019.0255
|
| 13 |
Yecheng Li, Xiaodong Yang, Yong Wu, Kui Zhao, Zhenyu Ye, Junjia Zhu, Xiaohui Xu, Xin Zhao, Chungen Xing. B7-H3 promotes gastric cancer cell migration and invasion. Oncotarget 2017; 8(42): 71725 doi: 10.18632/oncotarget.17847
|
| 14 |
RD Coletta, AFP Leme. B7‐H3 overexpression in oral cancer. Oral Diseases 2016; 22(3): 163 doi: 10.1111/odi.12413
|
| 15 |
Caroline E. Nunes-Xavier, Karine Flem Karlsen, Christina Tekle, Cathrine Pedersen, Tove Øyjord, Vesa Hongisto, Jahn M. Nesland, Ming Tan, Kristine Kleivi Sahlberg, Øystein Fodstad. Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors. Oncotarget 2016; 7(6): 6891 doi: 10.18632/oncotarget.6902
|
| 16 |
Lin Li, Siji Nian, Qin Liu, Bo Zhang, Wulemo Jimu, Chengwen Li, Zhanwen Huang, Qiaosen Hu, Yuanshuai Huang, Qing Yuan. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration. International Immunopharmacology 2024; 132: 111926 doi: 10.1016/j.intimp.2024.111926
|
| 17 |
Jing Li, You‑Yu Liu, Xue‑Feng Yang, Dao‑Fu Shen, Hong‑Zhi Sun, Ke‑Qiang Huang, Hua‑Chuan Zheng. Effects and mechanism of STAT3 silencing on the growth and apoptosis of colorectal cancer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.9368
|
| 18 |
Liyun Zhou, Zhenhua Jiang, Jing Gu, Wenhui Gu, Shuangyin Han. B7-H3 and digestive system cancers. European Journal of Inflammation 2021; 19: 205873922110005 doi: 10.1177/20587392211000581
|
| 19 |
Liang Lin, Li Cao, Yang Liu, Ke Wang, Xinwei Zhang, Xiaodan Qin, Dandan Zhao, Jie Hao, Yingjun Chang, Xiaojun Huang, Bei Liu, Jun Zhang, Jin Lu, Qing Ge. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3. Leukemia 2019; 33(6): 1475 doi: 10.1038/s41375-018-0331-6
|
| 20 |
Xiao Tan, Xiangyu Zhao. B7-H3 in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target. Chinese Medical Journal 2024; doi: 10.1097/CM9.0000000000003099
|
| 21 |
Zheng-Shi Wang, Ming Zhong, Yu-Hai Bian, Yi-Fei Mu, Shao-Lan Qin, Min-Hao Yu, Jun Qin. MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer. Oncotarget 2016; 7(28): 44266 doi: 10.18632/oncotarget.10023
|
| 22 |
Sangbin Lim, Hao Liu, Luciana Madeira da Silva, Ritu Arora, Zixing Liu, Joshua B. Phillips, David C. Schmitt, Tung Vu, Steven McClellan, Yifeng Lin, Wensheng Lin, Gary A. Piazza, Oystein Fodstad, Ming Tan. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α. Cancer Research 2016; 76(8): 2231 doi: 10.1158/0008-5472.CAN-15-1538
|
| 23 |
Xiaomao Hu, Minxian Xu, Yangzhi Hu, Na Li, Lei Zhou. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration. Cell Biochemistry and Biophysics 2021; 79(2): 397 doi: 10.1007/s12013-021-00975-0
|
| 24 |
Caili Chen, Yuelong Wang, Kunhong Zhong, Caiying Jiang, Lian Wang, Zhu Yuan, Chunlai Nie, Jianguo Xu, Gang Guo, Liangxue Zhou, Mu Yang, Aiping Tong. Frequent B7-H3 overexpression in craniopharyngioma. Biochemical and Biophysical Research Communications 2019; 514(2): 379 doi: 10.1016/j.bbrc.2019.04.142
|
| 25 |
Peixin Dong, Ying Xiong, Junming Yue, Sharon J. B. Hanley, Hidemichi Watari. B7H3 As a Promoter of Metastasis and Promising Therapeutic Target. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00264
|
| 26 |
Magdalena Kusaczuk, Rafał Krętowski, Marek Bartoszewicz, Marzanna Cechowska-Pasko. Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line. Tumor Biology 2016; 37(1): 931 doi: 10.1007/s13277-015-3781-8
|
| 27 |
Petar Rasic, Maja Jovanovic-Tucovic, Marija Jeremic, Slavisa M Djuricic, Zorica V Vasiljevic, Maja Milickovic, Djordje Savic. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World Journal of Gastrointestinal Oncology 2021; 13(8): 799-821 doi: 10.4251/wjgo.v13.i8.799
|
| 28 |
FEN LIU, TING ZHANG, SHITAO ZOU, BO JIANG, DONG HUA. B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer. Molecular Medicine Reports 2015; 12(4): 5455 doi: 10.3892/mmr.2015.4050
|
| 29 |
Xiaoman Zhang, Cuicui Xu, Cuicui Wang, Yuhui Pei, Min He, Zhicheng Wan, Jun Hou, Lianghai Wang. CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling. Clinical & Experimental Metastasis 2024; 41(2): 81 doi: 10.1007/s10585-024-10280-8
|
| 30 |
ZHANG ZHANG SUN, TING ZHANG, KUAN NING, RUAN ZHU, FEN LIU, SHOU-CHING TANG, BO JIANG, DONG HUA. B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu. Oncology Reports 2016; 36(1): 231 doi: 10.3892/or.2016.4808
|
| 31 |
Huan Zhang, Mengxin Zhu, Anjing Zhao, Tongguo Shi, Qinhua Xi. B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(1): 189031 doi: 10.1016/j.bbcan.2023.189031
|
| 32 |
Lipeng Tang, Songmin He, Ying Zhu, Bing Feng, Zuqing Su, Bo Liu, Fangfang Xu, Xieqi Wang, Hongying Liu, Chutian Li, Jie Zhao, Xirun Zheng, Caiyun Li, Chaoyue Sun, Chuanjian Lu, Guangjuan Zheng. Downregulated miR‐187 contributes to the keratinocytes hyperproliferation in psoriasis. Journal of Cellular Physiology 2019; 234(4): 3661 doi: 10.1002/jcp.27135
|
| 33 |
Ting Zhang, Yufen Jin, Xin Jiang, Longhai Li, Xiaowei Qi, Yong Mao, Dong Hua. Clinical and Prognostic Relevance of B7-H3 and Indicators of Glucose Metabolism in Colorectal Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.546110
|
| 34 |
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, Nafisesadat Amini, Kasra Talebi Anaraki, Motahhar Motahhary, Ensi Khalilipouya, Abdorrahman Harif Nashtifani, Sasan Shafiei, Marzieh Ramezani Farani, Noushin Nabavi, Shokooh Salimimoghadam, Amir Reza Aref, Rasoul Raesi, Afshin Taheriazam, Maliheh Entezari, Wenliang Zha. STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies. Environmental Research 2023; 233: 116458 doi: 10.1016/j.envres.2023.116458
|
| 35 |
Sylwia Mielcarska, Miriam Dawidowicz, Agnieszka Kula, Paweł Kiczmer, Hanna Skiba, Małgorzata Krygier, Magdalena Chrabańska, Jerzy Piecuch, Monika Szrot, Błażej Ochman, Julia Robotycka, Bogumiła Strzałkowska, Zenon Czuba, Dariusz Waniczek, Elżbieta Świętochowska. B7H3 Role in Reshaping Immunosuppressive Landscape in MSI and MSS Colorectal Cancer Tumours. Cancers 2023; 15(12): 3136 doi: 10.3390/cancers15123136
|
| 36 |
Xin Chen, Jie Li, Yue Chen, Ziting Que, Jiawei Du, Jianqiong Zhang. B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy. International Journal of Molecular Sciences 2022; 23(23): 15005 doi: 10.3390/ijms232315005
|
| 37 |
Zhenkun Yan, Sen Hong, Yumei Song, Miaomiao Bi. microR-4449 Promotes Colorectal Cancer Cell Proliferation via Regulation of SOCS3 and Activation of STAT3 Signaling. Cancer Management and Research 2021; : 3029 doi: 10.2147/CMAR.S266153
|
| 38 |
Changgang Wang, Haoran Feng, Xi Cheng, Kun Liu, Dongli Cai, Ren Zhao. Potential Therapeutic Targets of B7 Family in Colorectal Cancer. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00681
|
| 39 |
Jinye Ding, Yaoqi Sun, Zubaidan Sulaiman, Caixia Li, Zhongping Cheng, Shupeng Liu. Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer. International Journal of General Medicine 2023; : 367 doi: 10.2147/IJGM.S395553
|
| 40 |
Dongbao Li, Jun Wang, Jian Zhou, Shenghua Zhan, Yang Huang, Fei Wang, Zixiang Zhang, Dongming Zhu, Hua Zhao, Dechun Li, Gang Chen, Xinguo Zhu, Xin Zhao. B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells. Oncotarget 2017; 8(43): 74856 doi: 10.18632/oncotarget.20421
|
| 41 |
Jingyuan Zhao, Zibo Meng, Chao Xie, Chong Yang, Zhiqiang Liu, Shihong Wu, Bo Wang, Ping Fan, Xin Jin, Heshui Wu. B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. The International Journal of Biochemistry & Cell Biology 2019; 108: 84 doi: 10.1016/j.biocel.2019.01.011
|
| 42 |
Filippos Kontos, Theodoros Michelakos, Tomohiro Kurokawa, Ananthan Sadagopan, Joseph H. Schwab, Cristina R. Ferrone, Soldano Ferrone. B7-H3: An Attractive Target for Antibody-based Immunotherapy. Clinical Cancer Research 2021; 27(5): 1227 doi: 10.1158/1078-0432.CCR-20-2584
|
| 43 |
Xiao Sun, Lin Li, Hong-guang Ma, Pu Sun, Qi-lin Wang, Ting-ting Zhang, Yue-mao Shen, Wei-ming Zhu, Xia Li. Bisindolylmaleimide alkaloid BMA-155Cl induces autophagy and apoptosis in human hepatocarcinoma HepG-2 cells through the NF-κB p65 pathway. Acta Pharmacologica Sinica 2017; 38(4): 524 doi: 10.1038/aps.2016.171
|
| 44 |
Elizabeth Varghese, Samson Mathews Samuel, Aranka Brockmueller, Mehdi Shakibaei, Peter Kubatka, Dietrich Büsselberg. B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention. Cancer and Metastasis Reviews 2024; 43(1): 115 doi: 10.1007/s10555-023-10137-8
|
| 45 |
Bo Jiang, Fen Liu, ZhiHui Liu, Ting Zhang, Dong Hua. B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway. Tumor Biology 2016; 37(7): 9465 doi: 10.1007/s13277-015-4740-0
|
| 46 |
Theodoros Michelakos, Filippos Kontos, Omar Barakat, Luke Maggs, Joseph H. Schwab, Cristina R. Ferrone, Soldano Ferrone. B7-H3 targeted antibody-based immunotherapy of malignant diseases. Expert Opinion on Biological Therapy 2021; 21(5): 587 doi: 10.1080/14712598.2021.1862791
|
| 47 |
Binghao Zhao, Huanzhang Li, Yu Xia, Yaning Wang, Yuekun Wang, Yixin Shi, Hao Xing, Tian Qu, Yu Wang, Wenbin Ma. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy. Journal of Hematology & Oncology 2022; 15(1) doi: 10.1186/s13045-022-01364-7
|
| 48 |
Ruoqin Wang, Linqing Sun, Suhua Xia, Hongya Wu, Yanchao Ma, Shenghua Zhan, Guangbo Zhang, Xueguang Zhang, Tongguo Shi, Weichang Chen. B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the AKT/TM4SF1/SIRT1 pathway. Cell Death & Disease 2021; 12(5) doi: 10.1038/s41419-021-03736-2
|
| 49 |
Jingjing Zhang, Lu Liu, Sai Han, Yi Li, Qiuhong Qian, Qianqian Zhang, Hui Zhang, Ziyan Yang, Youzhong Zhang. B7-H3 is related to tumor progression in ovarian cancer. Oncology Reports 2017; 38(4): 2426 doi: 10.3892/or.2017.5858
|
| 50 |
Nhat-Chau TRUONG, Nhi-Thao HUYNH, Kmuong-Duy PHAM, Phuc-Van PHAM. Roles of cancer stem cells in cancer immune surveillance. Minerva Biotechnology and Biomolecular Research 2023; 35(1) doi: 10.23736/S2724-542X.23.02944-9
|
| 51 |
N. E. Kushlinskii, O. V. Kovaleva, A. A. Alferov, Yu. B. Kuzmin, E. A. Sushentsov, I. S. Stilidi. Expression of the immune checkpoint B7-H3 in tumor and its soluble form in serum of patients with bone neoplasms. Almanac of Clinical Medicine 2021; 49(3): 179 doi: 10.18786/2072-0505-2021-49-013
|
| 52 |
Bo Jiang, Ting Zhang, Fen Liu, Zhangzhang Sun, Hanping Shi, Dong Hua, Chen Yang. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer. Oncotarget 2016; 7(22): 31755 doi: 10.18632/oncotarget.9035
|
| 53 |
Seol Hwa Shin, Eun Jin Ju, Jin Park, Eun Jung Ko, Mi Ri Kwon, Hye Won Lee, Ga Won Son, Yun-Yong Park, Yeon Joo Kim, Si Yeol Song, Sangkwang Lee, Beom Seok Seo, Jin-A Song, Sangbin Lim, Doohwan Jung, Sunyoung Kim, Hyangsook Lee, Seok Soon Park, Seong-Yun Jeong, Eun Kyung Choi. ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02991-x
|
| 54 |
Wu-Tong Zhou, Wei-Lin Jin. B7-H3/CD276: An Emerging Cancer Immunotherapy. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.701006
|
| 55 |
Sarasa Meenakshi, Krushna Ch Maharana, Lokesh Nama, Udaya Kumar Vadla, Sameer Dhingra, Velayutham Ravichandiran, Krishna Murti, Nitesh Kumar. Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory
Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy. Current Neuropharmacology 2024; 22(7): 1248 doi: 10.2174/1570159X21666230809110444
|
| 56 |
Xiangqi Zhou, Shuhui Ouyang, Jianjun Li, Xin Huang, Xiaohong Ai, Yixin Zeng, Yuncheng Lv, Manbo Cai. The novel non‐immunological role and underlying mechanisms of B7‐H3 in tumorigenesis. Journal of Cellular Physiology 2019; 234(12): 21785 doi: 10.1002/jcp.28936
|
| 57 |
Wenjing Gu, Xinxing Zhang, Yongdong Yan, Yuqing Wang, Li Huang, Meijuan Wang, Xuejun Shao, Zhengrong Chen, Wei Ji. B7-H3 participates in the development of Asthma by augmentation of the inflammatory response independent of TLR2 pathway. Scientific Reports 2017; 7(1) doi: 10.1038/srep40398
|
| 58 |
Elodie Picarda, Kim C. Ohaegbulam, Xingxing Zang. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy. Clinical Cancer Research 2016; 22(14): 3425 doi: 10.1158/1078-0432.CCR-15-2428
|
| 59 |
Pengfei Zhang, Zhen Chen, Kuan Ning, Jian Jin, Xiaofeng Han. Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells. Biochemical and Biophysical Research Communications 2017; 490(3): 1132 doi: 10.1016/j.bbrc.2017.07.001
|